File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Addition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal cancer

TitleAddition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal cancer
Authors
KeywordsMedical sciences
Oncology
Issue Date2012
PublisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/
Citation
The 14th World Congress of the European Society for Medical Oncology (ESMO) on Gastrointestinal Cancer, Barcelona, Spain, 27–30 June 2012. In Annals of Oncology, 2012, v. 23 suppl. 4, p. iv94, abstract P-0224 How to Cite?
AbstractINTRODUCTION: A previous retrospective study revealed that oxaliplatin could induce splenic enlargement which in turn was associated with thrombocytopenia in patients with early stage colorectal cancer. However it has not still been known whether cetuximab aggravates or alleviates such effects in patients with metastatic colorectal cancer. We performed a retrospective study to investigate the effect of addition of cetuximab to oxaliplatin-based regimen as 1st line palliative chemotherapy on liver and spleen size and its association with thrombocytopenia in patients with metasta…
DescriptionPosters: P-0224
Persistent Identifierhttp://hdl.handle.net/10722/165129
ISSN
2014 Impact Factor: 7.040
2014 SCImago Journal Rankings: 3.138

 

DC FieldValueLanguage
dc.contributor.authorLee, Ven_US
dc.contributor.authorFang, WJen_US
dc.contributor.authorLam, KOen_US
dc.contributor.authorChoi, CWen_US
dc.contributor.authorNg, Sen_US
dc.contributor.authorHo, Gen_US
dc.contributor.authorCheng, Ten_US
dc.contributor.authorLiu, RKYen_US
dc.contributor.authorLeung, TWen_US
dc.contributor.authorKwong, DLWen_US
dc.contributor.authorZheng, SSen_US
dc.date.accessioned2012-09-20T08:15:21Z-
dc.date.available2012-09-20T08:15:21Z-
dc.date.issued2012en_US
dc.identifier.citationThe 14th World Congress of the European Society for Medical Oncology (ESMO) on Gastrointestinal Cancer, Barcelona, Spain, 27–30 June 2012. In Annals of Oncology, 2012, v. 23 suppl. 4, p. iv94, abstract P-0224en_US
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/10722/165129-
dc.descriptionPosters: P-0224-
dc.description.abstractINTRODUCTION: A previous retrospective study revealed that oxaliplatin could induce splenic enlargement which in turn was associated with thrombocytopenia in patients with early stage colorectal cancer. However it has not still been known whether cetuximab aggravates or alleviates such effects in patients with metastatic colorectal cancer. We performed a retrospective study to investigate the effect of addition of cetuximab to oxaliplatin-based regimen as 1st line palliative chemotherapy on liver and spleen size and its association with thrombocytopenia in patients with metasta…-
dc.languageengen_US
dc.publisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/en_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.subjectMedical sciences-
dc.subjectOncology-
dc.titleAddition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal canceren_US
dc.typeConference_Paperen_US
dc.identifier.emailLee, V: vhflee@hku.hken_US
dc.identifier.emailLam, KO: lamkaon@hku.hken_US
dc.identifier.emailLiu, RKY: ricoliu@hkucc.hku.hken_US
dc.identifier.emailLeung, TW: ltw920@hkucc.hku.hken_US
dc.identifier.emailKwong, DLW: dlwkwong@hku.hken_US
dc.identifier.authorityLee, V=rp00264en_US
dc.identifier.authorityLam, KO=rp01501en_US
dc.identifier.authorityKwong, DLW=rp00414en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1093/annonc/mds153-
dc.identifier.hkuros206044en_US
dc.identifier.hkuros227944-
dc.identifier.volume23en_US
dc.identifier.issuesuppl. 4-
dc.identifier.spageiv94en_US
dc.identifier.epageiv94en_US
dc.publisher.placeUnited Kingdom-
dc.customcontrol.immutablesml 140206-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats